PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 30045838-3 2018 Vadastuximab talirine is a CD33-directed antibody conjugated to pyrrolobenzodiazepine (PBD) dimers. pyrrolo(2,1-c)(1,4)benzodiazepine 64-85 CD33 molecule Homo sapiens 27-31 30045838-3 2018 Vadastuximab talirine is a CD33-directed antibody conjugated to pyrrolobenzodiazepine (PBD) dimers. pyrrolo(2,1-c)(1,4)benzodiazepine 87-90 CD33 molecule Homo sapiens 27-31 29196412-1 2018 Vadastuximab talirine (SGN-CD33A, 33A) is an antibody-drug conjugate consisting of pyrrolobenzodiazepine dimers linked to a monoclonal antibody targeting CD33, which is expressed in the majority of acute myeloid leukemia (AML) patients. pyrrolo(2,1-c)(1,4)benzodiazepine 83-104 CD33 molecule Homo sapiens 27-31 23770776-0 2013 SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML. pyrrolo(2,1-c)(1,4)benzodiazepine 66-87 CD33 molecule Homo sapiens 4-8 23770776-4 2013 We describe here the development of SGN-CD33A, a humanized anti-CD33 antibody with engineered cysteines conjugated to a highly potent, synthetic DNA cross-linking pyrrolobenzodiazepine dimer via a protease-cleavable linker. pyrrolo(2,1-c)(1,4)benzodiazepine 163-184 CD33 molecule Homo sapiens 40-44 23970353-1 2013 In this issue of Blood, Kung Sutherland et al report on the preclinical activity of SGN-CD33A, a humanized anti-CD33 antibody conjugated to a pyrrolobenzodiazepine (PBD) dimer via a protease-cleavable linker, against acute myeloid leukemia (AML) cells in vitro and in vivo. pyrrolo(2,1-c)(1,4)benzodiazepine 142-163 CD33 molecule Homo sapiens 88-92 23970353-1 2013 In this issue of Blood, Kung Sutherland et al report on the preclinical activity of SGN-CD33A, a humanized anti-CD33 antibody conjugated to a pyrrolobenzodiazepine (PBD) dimer via a protease-cleavable linker, against acute myeloid leukemia (AML) cells in vitro and in vivo. pyrrolo(2,1-c)(1,4)benzodiazepine 165-168 CD33 molecule Homo sapiens 88-92